CD276 and oral cavity squamous cell carcinoma: Moreover, modifications in B7-H3 glycosylation have been found to remodel the immune microenvironment, subsequently facilitating tumor progression in oral squamous cell carcinoma (OSCC) via enhanced binding efficacy of B7-H3 to DC-SIGN (DC-specific intercellular adhesion molecule 3) and Langerin on immune cells [176].